(Q46766394)

25 December 2017

title

CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation (English)

1 reference

25 December 2017

1 reference

2

Lineu César Werneck

1 reference

25 December 2017

author name string

Carlos Alexandre Twardowschy

1

1 reference

25 December 2017

Rosana Herminia Scola

3

1 reference

25 December 2017

Luciano De Paola

4

1 reference

25 December 2017

Carlos Eduardo Silvado

5

1 reference

25 December 2017

publication date

1 April 2011

1 reference

25 December 2017

Arquivos de Neuro-Psiquiatria

published in

1 reference

25 December 2017

volume

69

1 reference

25 December 2017

issue

2A

1 reference

25 December 2017

page(s)

153-158

1 reference

25 December 2017

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Evaluation of phenytoin dosage regimens based on genotyping of CYP2C subfamily in routinely treated Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Landmark article Sept 17, 1938: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. By H. Houston Merritt and Tracy J. Putnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

NICE guidance on newer drugs for epilepsy in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Genetic polymorphism of cytochrome P450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Prevalence of CYP2C9 polymorphisms in the south of Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

CYP2C9 genotyping and phenotyping in Brazilians: effects on the pharmacokinetics of the NSAID tenoxicam

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2011000200002

10.1590/S0004-282X2011000200002

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017